EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis

Wenqiang Zhou iD, Hui Zhu, Zhongquan Liu, Wenjuan Nie, Qingfeng Wang, Wenhui Shi, Yang Yang, Wenjie Qi iD, Yu Lu iD, Naihui Chu iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026

DOI: 10.1002/phar.70109 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2026. Verfasst von Wenqiang Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Nomograms, Linezolid, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Linezolid is essential for drug‐resistant tuberculosis (DR‐TB) treatment but causes frequent hematological toxicity. We developed a time‐dependent nomogram to predict this risk.

Methods

A prospective cohort of 201 patients with DR‐TB receiving linezolid (600 mg/day) was enrolled. Blood trough concentration (C min ) and clinical variables were measured. Multivariable Cox regression identified predictors, with a nomogram constructed to estimate toxicity probability at 1, 3, and 6 months. Model performance was assessed via calibration curves, C‐index, and time‐dependent area under the curve (AUC).

Results

Ninety‐six patients (47.8%) developed hematological adverse events (anemia: 26.4%, leukopenia: 14.4%, thrombocytopenia: 7.0%). Five predictors were significant: C min > 2.08 mg/L [Hazard Ratio (HR) = 2.87, p < 0.001]; lower baseline white blood cells (HR = 0.84, p = 0.003), hemoglobin (HR = 0.99, p = 0.033), and creatinine clearance rate (HR = 0.99, p = 0.001); and initial treatment (HR = 0.56 vs. retreatment, p = 0.011). The nomogram showed good discrimination (C‐index = 0.73) and calibration. Time‐dependent AUCs were 0.74 (1‐month), 0.79 (3‐month), and 0.80 (6‐month). Internal validation via bootstrapping (1000×) confirmed robustness.

Conclusions

This nomogram, integrating C min with baseline clinical factors, enables early identification of patients with DR‐TB at high risk for hematotoxicity and could guide pre‐emptive interventions. However, external validation is required to confirm its generalizability before widespread clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NomogramsLinezolidAntitubercular AgentsTuberculosis, Multidrug-ResistantHematologic DiseasesHumansFemaleMaleProspective StudiesMiddle AgedAdultTime FactorsCohort Studies

Stichwörter der Autor:innen

drug‐resistant tuberculosishematological toxicitylinezolidnomogramprediction model

Substanzen

LinezolidAntitubercular Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, and Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Tuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Wenqiang Zhou, Wenjie Qi, Yu Lu, Naihui Chu

Förderung

  • Ministry of Science and Technology

Zitieren

APA

Zhou, W., Zhu, H., Liu, Z., Nie, W., Wang, Q., Shi, W., Yang, Y., Qi, W., Lu, Y., & Chu, N. (2026). Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.70109

Vancouver

Zhou W, Zhu H, Liu Z, Nie W, Wang Q, Shi W, et al. Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026. doi:10.1002/phar.70109

BibTeX
@article{Zhou2026,
  author = {Zhou, Wenqiang and Zhu, Hui and Liu, Zhongquan and Nie, Wenjuan and Wang, Qingfeng and Shi, Wenhui and Yang, Yang and Qi, Wenjie and Lu, Yu and Chu, Naihui},
  title = {Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2026},
  doi = {10.1002/phar.70109}
}
Kostenlos starten →